1. Volgina GV. Kontrast-indutsirovannaya nefropatiya: patogenez, faktory riska, strategiya profilaktiki (chast' I). Nefrologiya i dializ 2006; 8(1): 69-77
2. Volgina GV. Kontrast-indutsirovannaya nefropatiya: patogenez, faktory riska, strategiya profilaktiki (chast' II). Nefrologiya i dializ 006; 8(2): 176-183
3. Bartholomew BA, Harjai KJ, Dukkipati S et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93(12):1515-1519
4. Bailey SR. Past and present attempts to prevent radiocontrast nephropathy. Rev Cardiovasc Med 2001; 2 [suppl 1]: S14-S20
5. McCullough PA, Sandberg KR. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 2003; 4 [suppl 5]: S3-S9
6. Mehran R, Ashby DT. Radiocontrast-induced acute renal failure: Allocations and outcomes. Rev Cardiovasc Med 2001; 2 [suppl 1]: S9-S13
7. Cox CD, Tsikouris JP. Preventing contrast nephropathy: What is the best strategy? A Review of the literature. J Clin Pharmacol 2004; 44: 327-337
8. Huber W, Eckel F, Hennig M et al. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: Acetylcysteine, Theophylline, or both? A randomized study. Radiology 2006; 239: 793-804
9. Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006; 295 (23): 2765-2779
10. Yoshinori I, Takahisa Y, Toshiaki S, Ryozo O. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci 2005; 97: 473-488
11. Rao QA, Newhouse JH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 2006; 239(2):392-397
12. Briguori C, Airoldi F, D’Andrea D et al. Renal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 2007; 115(10): 1211-1217